Timing. Relevance. Relationships.
Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.
Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
Pyxis Oncology, Inc.
The company signed a major contract or deal. An 8-K is the notice a US public company must file within four business days of a major event.
www.pyxisoncology.comAI Executive Summary
AI-powered analysis of 8-K filing content
Pyxis Oncology completed an underwritten public offering on October 1, 2026, raising $150 million through the issuance of common stock and warrants. This capital infusion strengthens the company's financial position to advance its oncology research and development pipeline.
Key Takeaways
Pyxis raised $150 million through an underwritten public offering of 36.0 million common shares and 1.9 million pre-funded warrants, with an additional 49.3 million common warrants issued
The offering was underwritten by Leerink Partners, Guggenheim Securities, and Wells Fargo Securities, indicating strong institutional backing
2 more takeaways
Filing Overview
What This Means
Pyxis Oncology, Inc. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
4 screens from a live account. No signup.